Gam Holding Ag Bausch Health Companies Inc. Transaction History

Gam Holding Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$18.89 - $31.89 $231,912 - $391,513	-12,277 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$20.88 - $25.66 $211,117 - $259,448	-10,111 Reduced 45.16%	12,277 $268,000
Q2 2019 Aug 12, 2019	SELL	$20.52 - $26.45 $121,539 - $156,663	-5,923 Reduced 20.92%	22,388 $565,000
Q1 2019 May 10, 2019	BUY	$20.23 - $26.29 $170,700 - $221,835	8,438 Added 42.46%	28,311 $699,000
Q4 2018 Feb 08, 2019	SELL	$17.64 - $28.32 $31,804 - $51,060	-1,803 Reduced 8.32%	19,873 $372,000
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $447,392 - $556,422	21,676 New	21,676 $557,000

275

279M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.95B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.